Celularity Historical Balance Sheet

CELUW Stock

USD 0.04 0.01 24.50%

Trend analysis of Celularity balance sheet accounts such as Short Long Term Debt Total of 40.5 M, Other Current Liabilities of 8.9 M or Total Current Liabilities of 39.3 M provides information on Celularity's total assets, liabilities, and equity, which is the actual value of Celularity to its prevalent stockholders. By breaking down trends over time using Celularity balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Celularity latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Celularity is a good buy for the upcoming year.

Celularity Inventory

6.13 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

About Celularity Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Celularity at a specified time, usually calculated after every quarter, six months, or one year. Celularity Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Celularity and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Celularity currently owns. An asset can also be divided into two categories, current and non-current.

Celularity Balance Sheet Chart

At this time, Celularity's Net Invested Capital is fairly stable compared to the past year.

Total Assets Short Long Term Debt Total Total Current Liabilities Non Current Assets Total

Add Fundamental

Total Assets

Total assets refers to the total amount of Celularity assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Celularity books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Celularity balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Celularity are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most accounts from Celularity's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Celularity current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.At this time, Celularity's Net Invested Capital is fairly stable compared to the past year.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	65.6M	65.4M	75.2M	40.5M
Total Assets	401.1M	143.9M	165.5M	286.9M

Short Long Term Debt Total Total Assets

Celularity balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Net Tangible Assets	Property Plant And Equipment Net	Warrants	Accounts Payable	Net Receivables	Good Will	Common Stock Total Equity	Retained Earnings Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse
Total Assets		0.68	0.81	0.57	-0.06	0.31	-0.73	0.74	1.0	-0.14	0.74	0.6	0.71	0.86	0.24	-0.76	0.84	-0.76	0.39	0.5	-0.22	0.78	-0.81	0.52	0.62	0.77
Short Long Term Debt Total	0.68		0.66	0.97	0.18	0.77	-0.9	0.23	0.68	0.04	0.23	0.94	0.32	0.6	0.07	-0.89	0.81	-0.89	0.84	0.92	-0.73	0.88	-0.87	0.95	0.18	0.89
Other Current Liab	0.81	0.66		0.68	-0.35	0.27	-0.78	0.75	0.77	0.39	0.75	0.57	0.77	0.93	-0.3	-0.84	0.92	-0.84	0.46	0.63	-0.28	0.85	-0.87	0.62	0.69	0.86
Total Current Liabilities	0.57	0.97	0.68		0.09	0.75	-0.92	0.2	0.55	0.28	0.2	0.92	0.3	0.59	-0.18	-0.91	0.82	-0.91	0.89	0.96	-0.78	0.89	-0.88	0.98	0.15	0.91
Total Stockholder Equity	-0.06	0.18	-0.35	0.09		0.52	0.05	-0.59	0.0	-0.4	-0.59	0.37	-0.73	-0.52	0.41	0.1	-0.15	0.1	0.1	-0.03	-0.1	-0.11	0.14	0.05	-0.78	-0.14
Net Debt	0.31	0.77	0.27	0.75	0.52		-0.63	-0.34	0.33	-0.06	-0.34	0.75	-0.22	0.12	0.13	-0.62	0.5	-0.61	0.67	0.73	-0.8	0.59	-0.5	0.76	-0.36	0.47
Retained Earnings	-0.73	-0.9	-0.78	-0.92	0.05	-0.63		-0.42	-0.71	-0.31	-0.42	-0.87	-0.48	-0.76	0.2	0.99	-0.94	0.99	-0.85	-0.91	0.76	-0.99	0.98	-0.92	-0.34	-0.95
Cash	0.74	0.23	0.75	0.2	-0.59	-0.34	-0.42		0.7	0.15	1.0	0.15	0.94	0.87	-0.1	-0.47	0.61	-0.47	0.08	0.18	0.17	0.5	-0.58	0.14	0.94	0.58
Non Current Assets Total	1.0	0.68	0.77	0.55	0.0	0.33	-0.71	0.7		-0.19	0.7	0.61	0.67	0.82	0.29	-0.74	0.81	-0.74	0.37	0.48	-0.21	0.76	-0.79	0.5	0.58	0.74
Non Currrent Assets Other	-0.14	0.04	0.39	0.28	-0.4	-0.06	-0.31	0.15	-0.19		0.15	0.11	0.15	0.25	-0.99	-0.31	0.31	-0.31	0.25	0.27	-0.21	0.31	-0.31	0.27	0.13	0.3
Cash And Short Term Investments	0.74	0.23	0.75	0.2	-0.59	-0.34	-0.42	1.0	0.7	0.15		0.15	0.94	0.87	-0.1	-0.47	0.61	-0.47	0.08	0.18	0.17	0.5	-0.59	0.14	0.94	0.58
Other Stockholder Equity	0.6	0.94	0.57	0.92	0.37	0.75	-0.87	0.15	0.61	0.11	0.15		0.14	0.46	-0.01	-0.84	0.77	-0.85	0.87	0.86	-0.7	0.83	-0.83	0.88	-0.01	0.85
Total Liab	0.71	0.32	0.77	0.3	-0.73	-0.22	-0.48	0.94	0.67	0.15	0.94	0.14		0.92	-0.09	-0.53	0.63	-0.53	0.15	0.32	0.01	0.56	-0.62	0.28	0.99	0.61
Total Current Assets	0.86	0.6	0.93	0.59	-0.52	0.12	-0.76	0.87	0.82	0.25	0.87	0.46	0.92		-0.16	-0.81	0.88	-0.81	0.43	0.59	-0.28	0.83	-0.86	0.57	0.85	0.83
Common Stock	0.24	0.07	-0.3	-0.18	0.41	0.13	0.2	-0.1	0.29	-0.99	-0.1	-0.01	-0.09	-0.16		0.2	-0.19	0.2	-0.16	-0.17	0.13	-0.2	0.2	-0.17	-0.09	-0.19
Net Tangible Assets	-0.76	-0.89	-0.84	-0.91	0.1	-0.62	0.99	-0.47	-0.74	-0.31	-0.47	-0.84	-0.53	-0.81	0.2		-0.97	1.0	-0.83	-0.91	0.73	-1.0	0.97	-0.89	-0.4	-0.95
Property Plant And Equipment Net	0.84	0.81	0.92	0.82	-0.15	0.5	-0.94	0.61	0.81	0.31	0.61	0.77	0.63	0.88	-0.19	-0.97		-0.97	0.71	0.8	-0.57	0.98	-0.96	0.78	0.51	0.93
Warrants	-0.76	-0.89	-0.84	-0.91	0.1	-0.61	0.99	-0.47	-0.74	-0.31	-0.47	-0.85	-0.53	-0.81	0.2	1.0	-0.97		-0.83	-0.91	0.72	-1.0	0.98	-0.89	-0.4	-0.95
Accounts Payable	0.39	0.84	0.46	0.89	0.1	0.67	-0.85	0.08	0.37	0.25	0.08	0.87	0.15	0.43	-0.16	-0.83	0.71	-0.83		0.94	-0.89	0.81	-0.77	0.88	0.02	0.8
Net Receivables	0.5	0.92	0.63	0.96	-0.03	0.73	-0.91	0.18	0.48	0.27	0.18	0.86	0.32	0.59	-0.17	-0.91	0.8	-0.91	0.94		-0.88	0.89	-0.85	0.97	0.18	0.87
Good Will	-0.22	-0.73	-0.28	-0.78	-0.1	-0.8	0.76	0.17	-0.21	-0.21	0.17	-0.7	0.01	-0.28	0.13	0.73	-0.57	0.72	-0.89	-0.88		-0.7	0.61	-0.84	0.14	-0.59
Common Stock Total Equity	0.78	0.88	0.85	0.89	-0.11	0.59	-0.99	0.5	0.76	0.31	0.5	0.83	0.56	0.83	-0.2	-1.0	0.98	-1.0	0.81	0.89	-0.7		-0.98	0.88	0.42	0.95
Retained Earnings Total Equity	-0.81	-0.87	-0.87	-0.88	0.14	-0.5	0.98	-0.58	-0.79	-0.31	-0.59	-0.83	-0.62	-0.86	0.2	0.97	-0.96	0.98	-0.77	-0.85	0.61	-0.98		-0.86	-0.5	-0.98
Common Stock Shares Outstanding	0.52	0.95	0.62	0.98	0.05	0.76	-0.92	0.14	0.5	0.27	0.14	0.88	0.28	0.57	-0.17	-0.89	0.78	-0.89	0.88	0.97	-0.84	0.88	-0.86		0.13	0.87
Non Current Liabilities Total	0.62	0.18	0.69	0.15	-0.78	-0.36	-0.34	0.94	0.58	0.13	0.94	-0.01	0.99	0.85	-0.09	-0.4	0.51	-0.4	0.02	0.18	0.14	0.42	-0.5	0.13		0.49
Capital Surpluse	0.77	0.89	0.86	0.91	-0.14	0.47	-0.95	0.58	0.74	0.3	0.58	0.85	0.61	0.83	-0.19	-0.95	0.93	-0.95	0.8	0.87	-0.59	0.95	-0.98	0.87	0.49

Click cells to compare fundamentals

Celularity Account Relationship Matchups

Celularity balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	431.0M	414.1M	401.1M	143.9M	165.5M	286.9M
Short Long Term Debt Total	30.6M	31.1M	65.6M	65.4M	75.2M	40.5M
Other Current Liab	18.3M	11.7M	16.4M	2.4M	11.1M	8.9M
Total Current Liabilities	26.7M	26.2M	62.1M	67.3M	77.4M	39.3M
Total Stockholder Equity	(531.4M)	99.4M	198.9M	41.0M	47.1M	49.5M
Net Debt	(23.7M)	(6.1M)	51.6M	39.0M	65.2M	68.4M
Retained Earnings	(563.6M)	(663.7M)	(645.5M)	(841.8M)	(757.6M)	(795.5M)
Cash	54.3M	37.2M	14.0M	227K	204.3K	194.1K
Non Current Assets Total	358.8M	376.9M	367.6M	124.1M	142.7M	258.1M
Non Currrent Assets Other	20.1M	39.8M	23.3M	26.9M	31.0M	32.5M
Cash And Short Term Investments	54.3M	37.2M	14.0M	227K	261.1K	248.0K
Liabilities And Stockholders Equity	431.0M	414.1M	401.1M	143.9M	165.5M	308.3M
Other Stockholder Equity	32.2M	763.1M	844.4M	882.7M	1.0B	510.0M
Total Liab	962.4M	314.7M	202.2M	102.9M	92.6M	88.0M
Total Current Assets	72.2M	37.2M	33.5M	19.8M	22.8M	28.8M
Common Stock	1K	12K	15K	19K	17.1K	16.2K
Property Plant And Equipment Net	90.1M	90.6M	88.7M	78.8M	90.6M	90.5M
Accounts Payable	5.4M	9.3M	5.8M	14.1M	16.3M	9.6M
Net Receivables	6.6M	5.2M	7.0M	10.0M	12.1M	8.1M
Common Stock Shares Outstanding	9.2M	6.7M	15.0M	19.4M	17.8M	13.1M
Non Current Liabilities Total	935.7M	288.5M	140.1M	35.6M	32.1M	30.5M
Inventory	3.9M	9.5M	5.3M	5.8M	6.6M	6.1M
Other Current Assets	7.4M	2K	7.3M	329K	1.7M	2.2M
Non Current Liabilities Other	74.6M	232.6M	106.3M	1.9M	2.2M	2.1M
Intangible Assets	125.4M	123.2M	121.0M	11.0M	9.9M	9.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Celularity Historical Balance Sheet

Celularity Inventory

6.13 Million

About Celularity Balance Sheet Analysis

Celularity Balance Sheet Chart

Total Assets

Total Current Liabilities

Non Current Assets Total

Celularity balance sheet Correlations

Celularity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Celularity balance sheet Accounts

Also Currently Popular

Additional Tools for Celularity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Warrants	+ 1.0	Net Tangible Assets
Net Tangible Assets	+ 0.99	Retained Earnings
Warrants	+ 0.99	Retained Earnings
Non Current Liabilities Total	+ 0.99	Total Liab

Common Stock Total Equity	- 1.0	Warrants
Common Stock Total Equity	- 1.0	Net Tangible Assets
Common Stock	- 0.99	Non Currrent Assets Other
Common Stock Total Equity	- 0.99	Retained Earnings
Capital Surpluse	- 0.98	Retained Earnings Total Equity
Retained Earnings Total Equity	- 0.98	Common Stock Total Equity